Who owns 10x Genomics (TXG)? Superinvestor holders
3 superinvestors of the 157 tracked here hold 10x Genomics (TXG) in their latest 13F filing, with $597.6M between them. Cathie Wood gives it the most weight: 3.26% of the reported portfolio. In their latest reported quarter, Stanley Druckenmiller opened a position; Cathie Wood reduced.
Key facts
- Superinvestors holding it
- 3 of 157
- Biggest holder
- Cathie Wood, $566.8M
- Largest weight
- Cathie Wood, 3.26%of their portfolio
- Combined value
- $597.6M
- Bought last quarter
- 1
- Sold last quarter
- 1
From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.
| # | Investor | Share of their portfolio | Value | Shares | Last quarter | Shares moved | Quarter |
|---|---|---|---|---|---|---|---|
| 1 | Cathie WoodARK Invest | 3.26% | $566.8M | 6.27M | ▼ Reduced 37% | −3.73M | Q3 2026 |
| 2 | Harvard endowmentHarvard Management Company | 0.39% | $15.4M | 170K | No change | 0 | Q3 2026 |
| 3 | Stanley DruckenmillerDuquesne Family Office | 0.36% | $15.5M | 403.1K | New | +403.1K | Q2 2026 |
Quarter by quarter
| Quarter | Filings in | Holders | Combined shares | Combined value | Bought | Sold |
|---|---|---|---|---|---|---|
| Q3 2026 | 92 | 2 | 6.44M | $582.2M | 0 | 1 |
| Q2 2026 | 157 | 3 | 10.58M | $405.5M | 1 | 1 |
| Q1 2026 | 157 | 2 | 11.89M | $252.4M | 0 | 1 |
| Q4 2025 | 157 | 2 | 12.84M | $209.4M | 1 | 0 |
| Q3 2025 | 157 | 2 | 12.06M | $141M | 0 | 2 |
| Q2 2025 | 157 | 3 | 14.54M | $168.3M | 1 | 2 |
| Q1 2025 | 156 | 3 | 14.96M | $130.6M | 1 | 2 |
| Q4 2024 | 156 | 4 | 15.41M | $221.2M | 2 | 1 |
A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.
Each holder's shares
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Cathie Wood | 6.27M | 10M | 11.72M | 12.67M | 11.89M | 13.89M | 12.85M | 11.94M |
| Harvard endowment | 170K | 170K | 170K | 170K | 170K | 170K | 170K | 170K |
| Stanley Druckenmiller | · | 403.1K | — | — | — | — | — | — |
| Peter Kolchinsky | · | — | — | — | — | 475.34K | 1.94M | 3.28M |
| Frank Sands | — | — | — | — | — | — | — | 12.54K |
A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.
Questions and answers
Which superinvestors own TXG?
In their latest 13F filings: Cathie Wood (3.26% of the portfolio, $566.8M), Harvard endowment (0.39% of the portfolio, $15.4M), Stanley Druckenmiller (0.36% of the portfolio, $15.5M).
Who bought TXG last quarter?
Stanley Druckenmiller (new position). “Last quarter” is each investor's latest reported quarter.
Who sold TXG last quarter?
Reduced: Cathie Wood (37% fewer shares).
How current is this?
It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.
Learn
Cite this page
Funkfolio, “Who owns 10x Genomics (TXG)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/TXG/superinvestors
Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.
Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to TXG by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.